Femasys (FEMY) vs Innovative Eyewear (LUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Femasys is the larger company by market cap ($17.1 million vs $7.8 million), about 2.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | FEMY | LUCY |
|---|---|---|
| Share price | $2.05 | $0.8967 |
| Market cap | $17.13M | $7.81M |
| 1-day change | +2.25% | -1.68% |
| YTD return | -82.25% | — |
| 1-year return | -82.87% | — |
| 5-year return | -98.54% | — |
| EPS (TTM) | $-3.28 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.20 | $2.05 |
| 52-week low | $1.94 | $0.65 |
| Distance from 52-week high | -90.79% | -56.26% |
| Analyst consensus | none | — |
| Avg. price target upside | +600.73% | — |
| Average volume | 722.09K | 3.81M |
| Shares outstanding | 8.38M | 8.71M |
| Employees | 51 | 13 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Femasys is about 2.2 times larger than Innovative Eyewear by market value ($17.13M vs $7.81M).
About Femasys
FEMY stock →Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.
Healthcare · Medical Instruments & Supplies · 51 employees
About Innovative Eyewear
LUCY stock →Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
Healthcare · Medical Instruments & Supplies · 13 employees
FEMY vs LUCY FAQ
Which is bigger, Femasys or Innovative Eyewear?
Femasys (FEMY) is larger, with a market capitalization of $17.13M compared with $7.81M for Innovative Eyewear (LUCY).
Are Femasys and Innovative Eyewear in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.